<?xml version="1.0" encoding="UTF-8" standalone="yes"?><ns0:RetrieveMultipleValueSetsResponse xmlns:ns0="urn:ihe:iti:svs:2008" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">    <ns0:DescribedValueSet ID="2.16.840.1.113883.3.464.1003.113.12.1047" displayName="Ehlers Danlos Syndrome" version="N/A">        <ns0:ConceptList>            <ns0:Concept code="10033001" codeSystem="2.16.840.1.113883.6.96" codeSystemName="SNOMEDCT" codeSystemVersion="2019-09" displayName="Ehlers-Danlos syndrome, non hydroxylysine deficient ocular type (disorder)"/>            <ns0:Concept code="17025000" codeSystem="2.16.840.1.113883.6.96" codeSystemName="SNOMEDCT" codeSystemVersion="2019-09" displayName="Ehlers-Danlos syndrome, type 4 (disorder)"/>            <ns0:Concept code="20766005" codeSystem="2.16.840.1.113883.6.96" codeSystemName="SNOMEDCT" codeSystemVersion="2019-09" displayName="Ehlers-Danlos syndrome, type 2 (disorder)"/>            <ns0:Concept code="25606004" codeSystem="2.16.840.1.113883.6.96" codeSystemName="SNOMEDCT" codeSystemVersion="2019-09" displayName="Ehlers-Danlos syndrome, hydroxylysine-deficient (disorder)"/>            <ns0:Concept code="30652003" codeSystem="2.16.840.1.113883.6.96" codeSystemName="SNOMEDCT" codeSystemVersion="2019-09" displayName="Ehlers-Danlos syndrome, type 3 (disorder)"/>            <ns0:Concept code="31798004" codeSystem="2.16.840.1.113883.6.96" codeSystemName="SNOMEDCT" codeSystemVersion="2019-09" displayName="Corneal fragility keratoglobus, blue sclerae AND joint hypermobility (disorder)"/>            <ns0:Concept code="398114001" codeSystem="2.16.840.1.113883.6.96" codeSystemName="SNOMEDCT" codeSystemVersion="2019-09" displayName="Ehlers-Danlos syndrome (disorder)"/>            <ns0:Concept code="4170004" codeSystem="2.16.840.1.113883.6.96" codeSystemName="SNOMEDCT" codeSystemVersion="2019-09" displayName="Ehlers-Danlos syndrome, procollagen proteinase resistant (disorder)"/>            <ns0:Concept code="50869007" codeSystem="2.16.840.1.113883.6.96" codeSystemName="SNOMEDCT" codeSystemVersion="2019-09" displayName="Ehlers-Danlos syndrome, type 8 (disorder)"/>            <ns0:Concept code="55711009" codeSystem="2.16.840.1.113883.6.96" codeSystemName="SNOMEDCT" codeSystemVersion="2019-09" displayName="Ehlers-Danlos syndrome, procollagen proteinase deficient (disorder)"/>            <ns0:Concept code="59399004" codeSystem="2.16.840.1.113883.6.96" codeSystemName="SNOMEDCT" codeSystemVersion="2019-09" displayName="Cutis laxa, x-linked (disorder)"/>            <ns0:Concept code="67202007" codeSystem="2.16.840.1.113883.6.96" codeSystemName="SNOMEDCT" codeSystemVersion="2019-09" displayName="Ehlers-Danlos syndrome, type 5 (disorder)"/>            <ns0:Concept code="70610001" codeSystem="2.16.840.1.113883.6.96" codeSystemName="SNOMEDCT" codeSystemVersion="2019-09" displayName="Ehlers-Danlos syndrome, recessive type 4 (disorder)"/>            <ns0:Concept code="71322004" codeSystem="2.16.840.1.113883.6.96" codeSystemName="SNOMEDCT" codeSystemVersion="2019-09" displayName="Ehlers-Danlos syndrome, familial joint laxity type (disorder)"/>            <ns0:Concept code="756.83" codeSystem="2.16.840.1.113883.6.103" codeSystemName="ICD9CM" codeSystemVersion="2013" displayName="Ehlers-Danlos syndrome"/>            <ns0:Concept code="83470009" codeSystem="2.16.840.1.113883.6.96" codeSystemName="SNOMEDCT" codeSystemVersion="2019-09" displayName="Ehlers-Danlos syndrome, type 1 (disorder)"/>            <ns0:Concept code="83586000" codeSystem="2.16.840.1.113883.6.96" codeSystemName="SNOMEDCT" codeSystemVersion="2019-09" displayName="Ehlers-Danlos syndrome, dysfibronectinemic (disorder)"/>            <ns0:Concept code="86667008" codeSystem="2.16.840.1.113883.6.96" codeSystemName="SNOMEDCT" codeSystemVersion="2019-09" displayName="Ehlers-Danlos syndrome, dominant type 4 (disorder)"/>            <ns0:Concept code="Q79.6" codeSystem="2.16.840.1.113883.6.90" codeSystemName="ICD10CM" codeSystemVersion="2020" displayName="Ehlers-Danlos syndromes"/>        </ns0:ConceptList>        <ns0:Source>National Committee for Quality Assurance</ns0:Source>        <ns0:Purpose>(Clinical Focus: This value set contains concepts that represent a diagnosis of Ehlers-Danlos syndrome.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis. ),(Inclusion Criteria: Includes only relevant concepts associated with diagnosis codes for Ehlers-Danlos syndrome. This is a grouping of ICD-9-CM, ICD-10-CM and SNOMED CT codes.),(Exclusion Criteria: No exclusions.)</ns0:Purpose>        <ns0:Definition>(2.16.840.1.113883.3.464.1003.113.11.1094:Ehlers Danlos Syndrome),(2.16.840.1.113883.3.464.1003.113.11.1095:Ehlers Danlos Syndrome),(2.16.840.1.113883.3.464.1003.113.11.1096:Ehlers Danlos Syndrome)</ns0:Definition>        <ns0:Type>Grouping</ns0:Type>        <ns0:Binding>Dynamic</ns0:Binding>        <ns0:Status>Active</ns0:Status>        <ns0:RevisionDate>2018-03-10</ns0:RevisionDate>    </ns0:DescribedValueSet></ns0:RetrieveMultipleValueSetsResponse>